BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li H, Zeng Y, Zhang H, Gu Z, Gong Q, Luo K. Functional gadolinium-based nanoscale systems for cancer theranostics. J Control Release 2021;329:482-512. [PMID: 32898594 DOI: 10.1016/j.jconrel.2020.08.064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang W, Wang M, Lv W, White F, Chen X, Obukhov A. Long-term treatment with gadopentetic acid or gadodiamide increases TRPC5 expression and decreases adriamycin nuclear accumulation in breast cancer cells.. [DOI: 10.21203/rs.3.rs-2414520/v1] [Reference Citation Analysis]
2 Qin Y, Geng X, Sun Y, Zhao Y, Chai W, Wang X, Wang P. Ultrasound nanotheranostics: Toward precision medicine. J Control Release 2023;353:105-24. [PMID: 36400289 DOI: 10.1016/j.jconrel.2022.11.021] [Reference Citation Analysis]
3 Gökçe E. Editorial for “ T1 Mapping Using MPRAGE Acquisitions: Application to the Measurement of the Concentration of Theranostic Agents in Tumors”. Magnetic Resonance Imaging 2022. [DOI: 10.1002/jmri.28511] [Reference Citation Analysis]
4 Paluszkiewicz P, Martuszewski A, Zaręba N, Wala K, Banasik M, Kepinska M. The Application of Nanoparticles in Diagnosis and Treatment of Kidney Diseases. Int J Mol Sci 2021;23:131. [PMID: 35008556 DOI: 10.3390/ijms23010131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang Q, Huang L, Zhu X, Zhou Y, Wang J, Su D, Liu L. MR/NIRF Dual-Mode Imaging of αvβ3 Integrin-Overexpressing Tumors Using a Lipopeptide-Based Contrast Agent. Mol Pharm 2021;18:4543-52. [PMID: 34677979 DOI: 10.1021/acs.molpharmaceut.1c00749] [Reference Citation Analysis]
6 Li Z, Yang Y, Wei H, Shan X, Wang X, Ou M, Liu Q, Gao N, Chen H, Mei L, Zeng X. Charge-reversal biodegradable MSNs for tumor synergetic chemo/photothermal and visualized therapy. J Control Release 2021;338:719-30. [PMID: 34509586 DOI: 10.1016/j.jconrel.2021.09.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 71] [Article Influence: 29.5] [Reference Citation Analysis]
7 Zhang J, Lin Z, Zhao M, Xu W, Nian F. Preparation and MRI performances of core-shell structural PEG salicylic acid-gadolinium composite nanoparticles. Journal of Rare Earths 2021. [DOI: 10.1016/j.jre.2021.09.006] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ruiz-Pulido G, Medina DI, Barani M, Rahdar A, Sargazi G, Baino F, Pandey S. Nanomaterials for the Diagnosis and Treatment of Head and Neck Cancers: A Review. Materials (Basel) 2021;14:3706. [PMID: 34279276 DOI: 10.3390/ma14133706] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
9 Zhang Q, Dai X, Zhang H, Zeng Y, Luo K, Li W. Recent advances in development of nanomedicines for multiple sclerosis diagnosis. Biomed Mater 2021;16:024101. [PMID: 33472182 DOI: 10.1088/1748-605X/abddf4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Perrelli A, Fatehbasharzad P, Benedetti V, Ferraris C, Fontanella M, De Luca E, Moglianetti M, Battaglia L, Retta SF. Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM). Expert Opin Drug Deliv 2021;18:849-76. [PMID: 33406376 DOI: 10.1080/17425247.2021.1873273] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
11 Zeng Y, Li Z, Zhu H, Gu Z, Zhang H, Luo K. Recent Advances in Nanomedicines for Multiple Sclerosis Therapy. ACS Appl Bio Mater 2020;3:6571-97. [DOI: 10.1021/acsabm.0c00953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]